Skip to content

Marilyn A. Huestis

30 papers in the library · 466 citations · publishing 1992-2026

Papers

Sort Most recent Most cited

Direct Comparison of (±) 3,4-Methylenedioxymethamphetamine (“Ecstasy”) Disposition and Metabolism in Squirrel Monkeys and Humans

Therapeutic Drug Monitoring June 1, 2009 Melanie Mueller, Erin A Kolbrich, Frank T. Peters et al.

The present study compared the disposition and metabolism of the recreational drug (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in squirrel monkeys and humans because the squirrel monkey has been extensively studied for MDMA neurotoxicity. A newly developed liquid chromatography-mass spectrometric procedure for simultaneous measurement of MDMA, 3,4-dihydroxymethamphetamine,...

Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine After Controlled Oral Administration to Young Adults

Therapeutic Drug Monitoring May 21, 2008 Erin A Kolbrich, Robert S. Goodwin, David A. Gorelick et al. 127 citations

This study examines the plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and metabolites 4-hydroxy-3-methoxymethamphetamine (HMMA), 3,4-methylenedioxyamphetamine (MDA), and 4-hydroxy-3-methoxyamphetamine (HMA) in young adults for up to 143 hours after drug administration. Seventeen female and male participants (black, white, and Hispanic) received placebo, low (1.0 mg/kg),...

Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users.

Psychopharmacology November 2007 Marilyn A. Huestis, Susan J Boyd, Stephen J Heishman et al.

A single 90-mg dose of the cannabinoid CB1 receptor antagonist rimonabant attenuates effects of smoked cannabis in humans. The objective of this study is to evaluate whether repeated daily 40-mg doses of rimonabant can attenuate effects of smoked cannabis to the same extent as a single higher (90 mg) dose. Forty-two male volunteers received one of three oral drug regimens in a randomized,...

The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers.

American heart journal March 2006 David A. Gorelick, Stephen J Heishman, Kenzie L Preston et al.

Animal studies suggest that cannabinoid CB1 receptors play a role in regulating blood pressure (BP). In human studies, activation of CB1 receptors by cannabis or its active ingredient, Delta9-tetrahydrocannabinol (THC), has modest and inconsistent effects on BP. We evaluated this phenomenon in 63 male cannabis smokers (mean [SD] age 27.7 +/- 5.4 years, 70% African American, 10.3 +/- 5.9 years...

Characterization of the absorption phase of marijuana smoking.

Clinical Pharmacology & Therapeutics July 1992 Marilyn A. Huestis, A H Sampson, B J Holicky et al.

Rapid blood collection, a paced smoking protocol and timely collection of physiologic and behavioral measures were used to characterize the absorption phase of marijuana smoking. Six healthy males smoked a single marijuana cigarette (placebo, 1.75%, or 3.55% delta-9-tetrahydrocannabinol) in a double-blind, randomized, Latin square study design. Rapid blood sampling with a continuous withdrawal...